Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise

NCT03760965 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
276
Enrollment
INDUSTRY
Sponsor class

Stopped Sanofi ended collaboration with Lexicon for Sotagliflozin. In China no regulatory pathway to transfer sponsorship during the conduct of ongoing studies.

Conditions

Interventions

Sponsor

Sanofi